SMS Lifesciences India Limited Cash Flow Conversion Efficiency

Latest as of March 2025: 0.161x

SMS Lifesciences India Limited cash flow conversion efficiency. Based on the latest financial reports, SMS Lifesciences India Limited (SMSLIFE) has a cash flow conversion efficiency ratio of 0.161x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs340.55 Million ≈ $3.68 Million USD) by net assets (Rs2.12 Billion ≈ $22.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of SMS Lifesciences India Limited (2016–2025)

Cash flow conversion efficiency of SMS Lifesciences India Limited from 2016 to 2025. This chart illustrates how SMS Lifesciences India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SMSLIFE stock price for real-time trading data and today's change.

SMS Lifesciences India Limited Cash Flow Conversion Ratio Explained

SMS Lifesciences India Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

SMS Lifesciences India Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SMS Lifesciences India Limited ranked by their cash flow conversion efficiency. Also see SMSLIFE market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Cryosite Ltd AU:CTE	0.361x
Eversendai Corporation Bhd KLSE:5205	0.039x
Better Life Group Co Ltd TW:1805	0.002x
Sunzen Biotech Bhd KLSE:0148	0.025x
Exel Composites Oyj HE:EXL1V	0.102x
Workpoint Entertainment Public Company Limited BK:WORK	0.000x
Rama Phosphates Limited NSE:RAMAPHO	0.011x
CVRx Inc NASDAQ:CVRX	-0.442x

Annual Cash Flow Conversion Efficiency for SMS Lifesciences India Limited (2016–2025)

The table below shows the annual cash flow conversion efficiency of SMS Lifesciences India Limited from 2016 to 2025. Review SMSLIFE free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs2.12 Billion ≈ $22.93 Million	Rs298.10 Million ≈ $3.22 Million	0.141x	+12.00%
2024-03-31	Rs1.94 Billion ≈ $20.94 Million	Rs243.06 Million ≈ $2.63 Million	0.126x	+14010783.13%
2023-03-31	Rs1.64 Billion ≈ $17.74 Million	Rs1.47K ≈ $15.89	0.000x	+100.00%
2022-03-31	Rs1.65 Billion ≈ $17.84 Million	Rs-112.41 Million ≈ $-1.22 Million	-0.068x	-125.04%
2021-03-31	Rs1.29 Billion ≈ $13.97 Million	Rs351.70 Million ≈ $3.80 Million	0.272x	+116.54%
2020-03-31	Rs1.16 Billion ≈ $12.52 Million	Rs145.47 Million ≈ $1.57 Million	0.126x	-55.44%
2019-03-31	Rs1.06 Billion ≈ $11.50 Million	Rs299.93 Million ≈ $3.24 Million	0.282x	+211.71%
2018-03-31	Rs884.08 Million ≈ $9.56 Million	Rs80.00 Million ≈ $865.21K	0.090x	-63.89%
2017-03-31	Rs808.34 Million ≈ $8.74 Million	Rs202.60 Million ≈ $2.19 Million	0.251x	-11.86%
2016-03-31	Rs691.28 Million ≈ $7.48 Million	Rs196.59 Million ≈ $2.13 Million	0.284x	--

About SMS Lifesciences India Limited

NSE:SMSLIFE India Biotechnology

Market Cap

$42.13 Million

Rs3.90 Billion INR

Market Cap Rank

#22332 Global

#1226 in India

Share Price

Rs1288.50

Change (1 day)

-6.64%

52-Week Range

Rs1150.70 - Rs1437.90

All Time High

Rs1747.88